(Q35597052)

9 August 2017

1 reference

title

Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease (English)

1 reference

9 August 2017

Corash L

1

1 reference

9 August 2017

Lin L

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Bone Marrow Transplantation

9 August 2017

published in

1 reference

9 August 2017

volume

33

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

1-7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704284

9 August 2017

exact match

0 references

cites work

Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Graft-versus-host reaction following blood product transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Immunopathogenic mechanisms of posttransfusion graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Immunocompetent Lymphocytes in Previously Frozen Washed Red Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

The rationale for pathogen inactivation treatment of platelet components--introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Use of irradiated blood components: practice parameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Inhibition of murine GVHD by PEN110 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

New phthalocyanines for photodynamic virus inactivation in red blood cell concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: comparison of dimethylmethylene blue and MB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Inactivation of pathogens in platelet concentrates by using a two-step procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

Practical dosimetric aspects of blood and blood product irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Transfusion-associated graft-versus-host disease caused by leukocyte-filtered stored blood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Radiosensitivity of T and B lymphocytes. II. Effect of irradiation on response of T cells to alloantigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Third party mediated graft rejection despite irradiation of blood products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Prevention of transfusion-associated graft-versus-host disease: selection of an adequate dose of gamma radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Blood component irradiation and prevention of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Assessment of donor T-cell function in cellular blood components by the CD69 induction assay: effects of storage, gamma radiation, and photochemical treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

PEN110 treatment functionally inactivates the PBMNCs present in RBC units: comparison to the effects of exposure to gamma irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Inhibition by albumin of merocyanine 540-mediated photosensitization of platelets and viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704284

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704284

1 reference

9 August 2017

1 reference